Ceftriaxone And Sulbactam For Injection IP

About Ceftriaxone And Sulbactam For Injection IP

Ceftiqas-SB Injection is a Ceftriaxone and Sulbactam for Injection IP formulation designed as a powerful antibiotic medication for the treatment and management of various bacterial infections. Each vial contains a combination of Ceftriaxone Sodium 1000 mg and Sulbactam Sodium 500 mg, which works together to provide enhanced antibacterial activity against susceptible bacterial strains. This combination helps inhibit bacterial growth while sulbactam supports the effectiveness of ceftriaxone by reducing bacterial resistance mechanisms. Available in an injection dosage form, Ceftiqas-SB Injection should be administered as prescribed by the physician for safe and effective use. It is not recommended for use in newly born or premature infants. Manufactured in India at a WHO-GMP certified manufacturing facility, the product is supplied in ampoule packaging with 1 vial per box to maintain quality and product integrity. The Maximum Retail Price (MRP) is as per the prevailing market rate. Ceftiqas-SB Injection is proudly marketed by Agus World Life LLP, ensuring reliable pharmaceutical standards and quality healthcare solutions.